Pascal Deschatelets, Chief Scientific Officer at Apellis Pharmaceuticals, Inc. (APLS), sold 1,748 shares at $64.14 ($112K) on 2024-01-29, disclosed to the SEC on 2024-01-31.
Open-market sale of $112k APLS by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $64.14 | 874 | $56K | 50.0% |
| 2 | $64.14 | 874 | $56K | 50.0% |
| Total | $64.14 avg | 1,748 | $112K | 100% |
| Filing → |
| APLS | SELL | 2026-01-15 | $51K | — | Filing → |
| APLS | SELL | 2025-01-30 | $24K | — | Filing → |
| APLS | SELL | 2025-01-23 | $240K | — | Filing → |